CytoImmune Therapeutics (Worldwide Rights for Novel EGFR Dual-targeting CAR) is Buildings and Property in United States that focus on novel EGFR business. They cover business area such as worldwide right, novel EGFR dual-target car, Chimeric Antigen Receptors (CAR, fusion protein, an intracellular co-stimulatory signal domain, Natural Killer (NK) cell, insertion, CAR nk cell therapy, initial clinical relevance, CAR-T, Cytokine Release Syndrome, neurotoxicity, Graft, Host Disease, GVHD.
-
Novel EGFR
-
San Diego, CA
United States
Private
worldwide rightnovel EGFR dual-target carChimeric Antigen Receptors (CARfusion proteinan intracellular co-stimulatory signal domainNatural Killer (NK) cellinsertionCAR nk cell therapyinitial clinical relevanceCAR-TCytokine Release SyndromeneurotoxicityGraftHost DiseaseGVHD
* We use standard office opening hours in near CytoImmune Therapeutics (Worldwide Rights for Novel EGFR Dual-targeting CAR)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
CytoImmune Therapeutics (Worldwide Rights For Novel EGFR Dual-targeting CAR) is Buildings and Property business from United States that founded in - ( years old in ), CytoImmune Therapeutics (Worldwide Rights for Novel EGFR Dual-targeting CAR) business is focusing on Novel EGFR.
CytoImmune Therapeutics (Worldwide Rights for Novel EGFR Dual-targeting CAR) headquarter office and corporate office address is located in San Diego, CA United States.
CytoImmune Therapeutics (Worldwide Rights for Novel EGFR Dual-targeting CAR) was founded in United States.
In , CytoImmune Therapeutics (Worldwide Rights for Novel EGFR Dual-targeting CAR) is currently focus on novel EGFR sector.
Above is snippet of Google Trends for "novel EGFR" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with CytoImmune Therapeutics (Worldwide Rights for Novel EGFR Dual-targeting CAR), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
